BSE filing, NSE: BLUEJET. Summary written from the filing by ALFA Finder's alert engine.
Blue Jet Healthcare Ltd: key numbers
- Share price
- ₹553.80
- Market cap
- ₹9,607 Cr
- Revenue (annual)
- ₹947.3 Cr
- Net profit (annual)
- ₹247.8 Cr
- P/E (TTM)
- 33.7×Sector 43.0×
- Promoter holding
- 73.15%-6.66% QoQ
- FII holding
- 0.81%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Blue Jet Healthcare Ltd
All →Blue Jet Healthcare Earnings Call Transcript: Key Takeaways
Record Q2 FY27 revenue of about ₹376 Cr (+28% QoQ), but gross margin fell 4ppt to 49% on West Asia raw-material costs. Management gave no numerical forward guidance; margin recovery depends on price hikes from Q3.
Blue Jet Healthcare Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs3,757mn (record, +127% YoY), EBITDA Rs1,188mn (31.6%), PAT Rs1,025mn (27.3%). H1 FY27 revenue Rs6,689mn, PAT Rs1,808mn. Growth led by pharma intermediates and API.
Blue Jet Healthcare Q2 FY27 Results: Net Profit ₹102.5 Cr, Up 96.7% YoY
Blue Jet Healthcare reported standalone financial results for the quarter ended September 30, 2026. Revenue from operations reached Rs.375.74 Crore with a net profit of Rs.102.52 Crore.
- Key figure
- Net profit ₹102.5 Cr · +96.7% YoY
Blue Jet Healthcare Board Meeting Date
Blue Jet Healthcare scheduled a board meeting on November 5, 2026, to consider Q1 FY27 unaudited results. No financial figures are disclosed.
Blue Jet Healthcare Other Announcement
Blue Jet Healthcare Limited filed its quarterly shareholding pattern for the period ended 30 September 2026 under Regulation 31(1)(b). Promoter and promoter group hold about 73.15% of the equity.
Blue Jet Healthcare Other Announcement
Blue Jet Healthcare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory norms.
Other other announcement announcements
All →Sustainable Energy Infra Trust Other Announcement
Sustainable Energy Infra Trust says its RTA, KFin Technologies, moves its corporate office from December 1, 2026. Correspondence should now go to the new Kokapet address.
Kingfa Science & Technology (India) Other Announcement
Kingfa filed CARE Ratings' monitoring report on its Rs.500 crore preferential issue proceeds. Nil deviation from issue objects was reported for the quarter ended September 30, 2026.
Stallion India Fluorochemicals Other Announcement
Stallion India Fluorochemicals cancelled its analyst/investor meeting scheduled for 6 November 2026. The virtual meeting carried no financial or business event.
Tamilnad Mercantile Bank Other Announcement
Tamilnad Mercantile Bank revised its MCLR rates effective November 7, 2026. The one-year MCLR rises from 9.35% to 9.45%.
Vivid Electromech Other Announcement
Vivid Electromech filed IPO proceeds utilisation reports for the quarter ended September 30, 2026. Cumulative utilisation stood at Rs 81.64 Crore.
Molbio Diagnostics Other Announcement
Molbio Diagnostics filed CRISIL's monitoring agency report on IPO proceeds utilisation for the quarter ended 30 September 2026. The report states no deviation from the issue objects.